Effects of human soluble epoxide hydrolase polymorphisms on isoprenoid phosphate hydrolysis
- 1 March 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 341 (1) , 254-260
- https://doi.org/10.1016/j.bbrc.2005.12.180
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Soluble epoxide hydrolase is a therapeutic target for acute inflammationProceedings of the National Academy of Sciences, 2005
- Soluble Epoxide Hydrolase Is a Main Effector of Angiotensin II–Induced HypertensionHypertension, 2005
- Distribution of Soluble Epoxide Hydrolase and of Cytochrome P450 2C8, 2C9, and 2J2 in Human TissuesJournal of Histochemistry & Cytochemistry, 2004
- Structure of Human Epoxide Hydrolase Reveals Mechanistic Inferences on Bifunctional Catalysis in Epoxide and Phosphate Ester Hydrolysis,Biochemistry, 2004
- The N-terminal domain of mammalian soluble epoxide hydrolase is a phosphataseProceedings of the National Academy of Sciences, 2003
- The soluble epoxide hydrolase encoded by EPXH2 is a bifunctional enzyme with novel lipid phosphate phosphatase activityProceedings of the National Academy of Sciences, 2003
- Targeted Disruption of Soluble Epoxide Hydrolase Reveals a Role in Blood Pressure RegulationJournal of Biological Chemistry, 2000
- Crystal Structure of Human Squalene SynthaseJournal of Biological Chemistry, 2000
- Anti-inflammatory Properties of Cytochrome P450 Epoxygenase-Derived EicosanoidsScience, 1999
- Sterols and Isoprenoids: Signaling Molecules Derived from the Cholesterol Biosynthetic PathwayAnnual Review of Biochemistry, 1999